Share Value Dilution Through the Exercise of Stock Options
First written in FY2021. 2 of 6 entries say "Mitigated", first in FY2022-Q2. Latest entry: FY2024.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2024MitigatedAnnual report
「Third Series Stock Acquisition Rights; before vesting: 67,300 at end of previous fiscal year; expired: 67,300; unvested balance: —」
All 67,300 stock acquisition rights outstanding at the end of the previous fiscal year expired, leaving no applicable stock acquisition rights at the end of the current fiscal year. - FY2023RestatedAnnual report
「Number of stock acquisition rights (rights) * 67,300 (Note 1)」
The 67,300 Third Series Stock Acquisition Rights issued on 17 January 2023 remained outstanding and unexercised at the end of the fiscal year. - FY2023-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 15 December 2022, we resolved to issue stock acquisition rights as stock options to our directors and employees, and issued them on 17 January 2023.」
The stock acquisition rights resolved on in the previous fiscal year were actually issued on 17 January 2023. A total of 67,300 rights were issued, which could result in potential dilution of equity value upon exercise. - FY2022Reissuance of stock acquisition rightsAnnual report
「At a meeting of the Board of Directors held on 15 December 2022, we resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights, in the form of paid stock options, to our directors and employees.」
Although no existing stock acquisition rights remained as of the end of September 2022, a resolution was subsequently passed to issue 70,800 paid stock options, creating potential dilution exposure again. - FY2022-Q2MitigatedAnnual report
「1. Stock option program: Not applicable. 2. Other stock acquisition rights, etc.: Not applicable.」
Regarding the potential dilution from stock acquisition rights disclosed in the previous filing, the second-quarter report states that there are no stock options or other stock acquisition rights. - FY2021First statedAnnual report
「As of the filing date of this document, 562,500 shares are subject to stock acquisition rights, representing a potential dilution ratio of 9.00% against the company's total 6,250,000 issued shares.」
The company discloses the number of shares subject to stock acquisition rights and the potential dilution ratio, indicating the possibility of dilution upon exercise.